Latest filing published 19 May 2022 for OncoCyte Corp.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Li Yu: trading record in brief
Li Yu appears in our data through filings on Insight Molecular Diagnostics Inc. shares, published by SEC (Form 4). In total, 2 filings cover trades dated 18 May 2022.
The open-market record consists of 1 sale worth €8,848, with no purchase. Other entries cover 1 option exercise.
On 19 May 2022 came the latest disclosure, an open-market sale for €8,848 in Insight Molecular Diagnostics Inc. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Li Yu
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 25,000 shares0Common Stock, no par valueSEC:0001493152-22-014518:0
1 of 1 declaration
